Vincent DeVita, Jr, MD
- Amy and Joseph Perella Professor of Medicine (Medical Oncology) and Professor of Epidemiology (Chronic Diseases)
Dr. Vincent DeVita, the Amy and Joseph Perella Professor of Medicine at the Yale Cancer Center and Professor of Epidemiology and Public Health, was the Director of the Yale Cancer Center from 1993 to 2003. He spent the early part of his career at the National Cancer Institute (NCI), and in 1980, the President of the United States appointed him director of the NCI and the National Cancer Program, a position he held until 1988. From 1988 until be returned to Yale in 1993, he was Physician-in-Chief and Attending Physician at Memorial Sloan Kettering Cancer Center and a member of the Program of Molecular Pharmacology. Dr. DeVita has earned international recognition for his accomplishments as a pioneer in the field of Oncology. While at the NCI, he developed combination chemotherapy programs that ultimately led to an effective regimen of curative chemotherapy for Hodgkin's disease and diffuse large cell lymphomas. Along with colleagues at the NCI, he developed the four-drug combination, known by the acronym MOPP, which increased the cure rate for patients with advanced Hodgkin's disease from nearly zero to over 70%. In addition, in collaboration with Dr. George Canellos, he developed the combination chemotherapy CMF, which still remains a useful therapy for breast cancer. He earned his Bachelor of Science degree from the College of William and Mary in 1957. He was awarded his M.D. degree with distinction from the George Washington University School of Medicine in 1961. Dr. DeVita currently serves on the editorial boards of numerous scientific journals and is the author or co-author of more than 450 scientific articles. He is one of the three editors of "Cancer: Principles & Practice of Oncology", now in its 10th edition, and serves as the Editor-in-Chief of The Cancer Journal. Dr. DeVita, along with his daughter, Elizabeth DeVita-Raeburn recently wrote a personal book entitled "The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on cancer is Winnable--and How We Can Get There".
- MD, George Washington University, 1961
- DeVita VT, DeVita-Raeburn E. The Death of Cancer: After Fifty Years on the Front Lines of Medicine, a Pioneering Oncologist Reveals Why the War on Cancer is Winnable--and How We Can Get There. New York, NY, Sarah Crighton Books at Farrar, Straus and Giroux, November 3, 2015.
- DeVita VT, Lawrence TS, Rosenberg SA (Eds). The Cancer Journal: The Journal of Principles & Practice of Oncology, V. 23 (1-6). Philadelphia, PA, Wolters Kluwer Health/Lippincott Williams & Wilkins Publishers, 2017.
- Chu E, DeVita VT. Physicians' Cancer Chemotherapy Drug Manual. Sudbury, MA, Jones and Bartlett Learning, LLC, 2017.
- DeVita VT, Lawrence TS, Rosenberg SA, (Eds) DeVita, Hellman, and Rosenberg's Cancer: Principles & Practice of Oncology, 10th Edition. Philadelphia: Wolters Kluwer Health/Lippincott Williams & Wilkins, 2014.
- DeVita VT, Lawrence TS, Rosenberg SA (Eds). Cancer: Principles & Practice of Oncology: Primer of the Molecular Biology of Cancer, 2nd Edition. Philadelphia, PA, Wolters Kluwer Health/Lippincott, Williams, and Wilkins, 2015.
- DeVita VT, Eggermont AMM, Hellman S, Kerr D. NRCO 10 Year Viewpoint Anniversary: Clinical cancer research: the past, present and the future. NRCO 11(11) Nov. 2014.
- Canellos GP, Rosenberg SA, Friedberg JW, Lister TA, DeVita VT. Treatment of Hodgkin's Lymphoma: A 50-Year Perspective. JCO 32(3) Jan 20, 2014.
- Rose M, DeVita VT, Lawrence TS, Rosenberg SA (Eds). Oncology in Primary Care. Philadelphia, PA, Lippencott Williams and Wilkens, May 2013.
- DeVita VT, Rosenberg SA. Two hundred years of cancer research. NEJM 2012; 366;2207-14.
- Cancer: Principles & Practices of Oncology
Philadelphia, United States (2014-Present)
Dr. DeVita is one of three editors of CANCER: Principles & Practices of Oncology, 10th edition. CANCER is a comprehensive textbook in the field of cancer medicine; it is the most widely-read text on cancer in the world (and notably in Europe, India, and Asia). The textbook is published by Wolters Kluwer Health/Lippincott, Williams, and Wilkins.
Wolters Kluwer Health/Lippincott, Williams, and Wilkins, Publishers, Wolters Kluwer Health/Lippincott, Williams, and Wilkins, Publishers
- Oncology, Nature Reviews Clinical Oncology
London, United Kingdom (2008-Present)
Dr. DeVita is an editor of Nature Reviews Clinical Oncology (NRCO), a journal by Nature Publishing Group. NRCO is based in London, with international leadership. Macmillan Publishers Limited.
Nature Reviews Clinical Oncology, Nature Reviews Clinical Oncology
- Fellow of the American Association for Cancer Research (FAACR)
- President American Cancer Society
- Fellow of the American Society of Clinical Oncology (FASCO)
- Awarded Honoris Causa in Medicine Degree
- FREDDIE Award, a Public Service Award.
- Elected, European Academy of Sciences
- Honorary Life Member
- Giants of Cancer Care 2013
- Distinguished Medical Science Award
- ASCO Statesman Award
- Amy and Joseph Perella Chair to be named Vincent T. DeVita Professor of Medicine upon his retirement.
- Board of Permanent OfficersYale School of Medicine
- Honorary Degree CommitteeYale University(2000 - 2006)
- Appointment and Promotions SubcommitteeYale Comprehensive Cancer Center(2000 - 2009)
- Ex officio member, Scientific Advisory BoardYale Comprehensive Cancer Center
- Promotions Committee YCC Section of Medical OncologyYale Comprehensive Cancer Center
- Yale Cancer Center Board of AdvisorsYale Comprehensive Cancer Center(2003 - 2009)
- Thesis Committee Member Pathology DepartmentYale University School of Medicine(2005 - 2007)
- Dean Search CommitteeYale School of Nursing(2005 - 2006)
- Campaign CommitteeSmilow Cancer Hospital at Yale-New Haven
- Evaluation/Review CommitteeDepartment of Epidemiology and Public Health, School of Public Health